← All trials
NCT06880848
Phase 4Interventional
Studies of FDA-approved drugs to delineate additional information including the drug's risks, benefits, and optimal use.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jun 21, 2023
- Primary completion
- Aug 26, 2025
- Completion date
- Aug 26, 2025
- First posted
- Mar 18, 2025
- Last posted
- Sep 24, 2025
- Enrollment
- 160
- Arms / groups
- 1 / —
- Source
- AACT · ctgov ingestion
Sponsors
- JemincareLead sponsor
- Sun PharmaceuticalsCollaborator
- Peking UniversityOfficial
- Government of ChinaCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.